Literature DB >> 21464255

Efficacy of simulated cefditoren versus amoxicillin-clavulanate free concentrations in countering intrastrain ftsI gene diffusion in Haemophilus influenzae.

Natalia González1, Lorenzo Aguilar, David Sevillano, Maria-Jose Giménez, Luis Alou, Fabio Cafini, Martha Torrico, Ana-Maria López, Pilar Coronel, Jose Prieto.   

Abstract

This study explores the effects of cefditoren (CDN) versus amoxicillin-clavulanic acid (AMC) on the evolution (within a single strain) of total and recombined populations derived from intrastrain ftsI gene diffusion in β-lactamase-positive (BL⁺) and β-lactamase-negative (BL⁻) Haemophilus influenzae. DNA from β-lactamase-negative, ampicillin-resistant (BLNAR) isolates (DNA(BLNAR)) and from β-lactamase-positive, amoxicillin-clavulanate-resistant (BLPACR) (DNA(BLPACR)) isolates was extracted and added to a 10⁷-CFU/ml suspension of one BL⁺ strain (CDN MIC, 0.007 μg/ml; AMC MIC, 1 μg/ml) or one BL⁻ strain (CDN MIC, 0.015 μg/ml; AMC MIC, 0.5 μg/ml) in Haemophilus Test Medium (HTM). The mixture was incubated for 3 h and was then inoculated into a two-compartment computerized device simulating free concentrations of CDN (400 mg twice a day [b.i.d.]) or AMC (875 and 125 mg three times a day [t.i.d.]) in serum over 24 h. Controls were antibiotic-free simulations. Colony counts were performed; the total population and the recombined population were differentiated; and postsimulation MICs were determined. At time zero, the recombined population was 0.00095% of the total population. In controls, the BL⁻ and BL⁺ total populations and the BL⁻ recombined population increased (from ≈3 log₁₀ to 4.5 to 5 log₁₀), while the BL⁺ recombined population was maintained in simulations with DNA(BLPACR) and was decreased by ≈2 log₁₀ with DNA(BLNAR). CDN was bactericidal (percentage of the dosing interval for which experimental antibiotic concentrations exceeded the MIC [ft>MIC], >88%), and no recombined populations were detected from 4 h on. AMC was bactericidal against BL⁻ strains (ft>MIC, 74.0%) in DNA(BLNAR) and DNA(BLPACR) simulations, with a small final recombined population (MIC, 4 μg/ml; ft>MIC, 30.7%) in DNA(BLPACR) simulations. When AMC was used against the BL⁺ strain (in DNA(BLNAR) or DNA(BLPACR) simulations), the bacterial load was reduced ≈2 log₁₀ (ft>MIC, 44.3%), but 6.3% and 32% of the total population corresponded to a recombined population (MIC, 16 μg/ml; ft>MIC, 0%) in DNA(BLNAR) and DNA(BLPACR) simulations, respectively. AMC, but not CDN, unmasked BL⁺ recombined populations obtained by transformation. ft>MIC values higher than those classically considered for bacteriological response are needed to counter intrastrain ftsI gene diffusion by covering recombined populations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21464255      PMCID: PMC3101387          DOI: 10.1128/AAC.01719-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence.

Authors:  P Ball; F Baquero; O Cars; T File; J Garau; K Klugman; D E Low; E Rubinstein; R Wise
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

2.  Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains.

Authors:  Stephen Murchan; Mary Elizabeth Kaufmann; Ariane Deplano; Raf de Ryck; Marc Struelens; Christina Elsberg Zinn; Vivian Fussing; Saara Salmenlinna; Jaana Vuopio-Varkila; Névine El Solh; Christina Cuny; Wolfgang Witte; Panayotis T Tassios; Nikolas Legakis; Willem van Leeuwen; Alex van Belkum; Anna Vindel; Idoia Laconcha; Javier Garaizar; Saara Haeggman; Barbro Olsson-Liljequist; Ulrika Ransjo; Geoffrey Coombes; Barry Cookson
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Carriage of multiple ribotypes of non-encapsulated Haemophilus influenzae in aboriginal infants with otitis media.

Authors:  H C Smith-Vaughan; A J Leach; T M Shelby-James; K Kemp; D J Kemp; J D Mathews
Journal:  Epidemiol Infect       Date:  1996-04       Impact factor: 2.451

4.  Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study Group.

Authors:  S R Scriver; S L Walmsley; C L Kau; D J Hoban; J Brunton; A McGeer; T C Moore; E Witwicki
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

5.  Transfer of Haemophilus influenzae chromosomal genes by cell-to-cell contact.

Authors:  W L Albritton; J K Setlow; L Slaney
Journal:  J Bacteriol       Date:  1982-12       Impact factor: 3.490

6.  Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain.

Authors:  Emilio Pérez-Trallero; Celia García-de-la-Fuente; César García-Rey; Fernando Baquero; Lorenzo Aguilar; Rafael Dal-Ré; Juan García-de-Lomas
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

7.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

Review 8.  Cefditoren pivoxil: a review of its use in the treatment of bacterial infections.

Authors:  Keri Wellington; Monique P Curran
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model.

Authors:  Luis Alou; Lorenzo Aguilar; David Sevillano; María-José Giménez; Olatz Echeverría; María-Luisa Gómez-Lus; José Prieto
Journal:  J Antimicrob Chemother       Date:  2005-01-13       Impact factor: 5.790

10.  Mutant ftsI genes in the emergence of penicillin-binding protein-mediated beta-lactam resistance in Haemophilus influenzae in Norway.

Authors:  D Skaare; A-G Allum; I L Anthonisen; A Jenkins; A Lia; L Strand; Y Tveten; B-E Kristiansen
Journal:  Clin Microbiol Infect       Date:  2009-09-08       Impact factor: 8.067

View more
  4 in total

Review 1.  Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.

Authors:  Daniel Gonzalez; Stephan Schmidt; Hartmut Derendorf
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

Review 2.  Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults.

Authors:  María-José Giménez; Lorenzo Aguilar; Juan José Granizo
Journal:  Multidiscip Respir Med       Date:  2018-11-02

3.  Evaluation of Drug Susceptibility of Microorganisms in Odontogenic Inflammations and Dental Surgery Procedures Performed on an Outpatient Basis.

Authors:  Mateusz Bogacz; Tadeusz Morawiec; Joanna Śmieszek-Wilczewska; Katarzyna Janowska-Bogacz; Anna Bubiłek-Bogacz; Rafał Rój; Karolina Pinocy; Anna Mertas
Journal:  Biomed Res Int       Date:  2019-10-07       Impact factor: 3.246

Review 4.  [Three keys to the appropriate choice of oral antibiotic treatment in the respiratory tract infections].

Authors:  R Menéndez; R Cantón; A García-Caballero; J Barberán
Journal:  Rev Esp Quimioter       Date:  2019-12-04       Impact factor: 1.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.